Epidemiology and Laboratory Capacity (ELC) HAI/AR Program Funded Activities (August 2019 – July 2020)
Many of these activities complement other CDC AR investments, collectively known as CDC’s AR Solutions Initiative, to fight antibiotic resistance across healthcare, community, and food in all 50 states, six large cities, Puerto Rico, Guam, and US Virgin Islands.
- Rapid Response, Containment, and Prevention Capacity– Coordination and implementation of HAI/AR prevention activities across the state/city/territory, managing the program’s advisory group, and implementing and reporting on progress of the HAI/AR plan. Activities focus on promoting proven prevention practices, detecting and responding to HAI/AR outbreaks, and increasing the use of National Healthcare Safety Network (NHSN) to track and prevent HAIs and transmission of AR pathogens in healthcare settings.
- Rapid Detection of AR Pathogens through Enhanced State HAI/AR Laboratory Capacity, Coordination and Outreach – As part of AR Lab Network activities, all state public health laboratories and four major cities/territories receive support and lab capacity to detect, confirm, and characterize AR pathogens and novel resistance mechanisms. This will improve response to outbreaks and containment of AR threats in healthcare such as CRE, carbapenem-resistant Pseudomonas aeruginosa (CRPA), and C. auris.
- Educational Efforts to Promote Appropriate Antibiotic Use – Assists state and local-level agencies in implementing health communication programs and behavioral interventions to promote appropriate antibiotic use. These programs aim to improve the knowledge, attitudes and behaviors of the general public and health care providers, contributing to a reduction in inappropriate prescribing and antibiotic resistance.
- Coordinated Prevention and Stewardship – Support for state and local health departments to improve tracking of antibiotic use and resistance and expanding coordinated prevention and stewardship activities across the spectrum of healthcare.
- External Data Validation – Build and sustain health department programs’ ability to ensure the quality of healthcare-associated infection data reported to the National Healthcare Safety Network (NHSN).
- Antibiotic Resistance Laboratory Network (AR Lab Network) – Support the AR Lab Network to track changes in resistance and help identify and respond to outbreaks faster. The AR Lab Network includes seven regional labs, the National Tuberculosis Molecular Surveillance Center (National TB Center), and labs in 50 states, four cities, and Puerto Rico. It supports nationwide lab capacity to rapidly detect antibiotic resistance in healthcare, food, and the community, and inform local responses to prevent spread and protect people. The AR Lab Network is capable of detecting known and emerging resistance threats, such as increased testing nationwide for the fungal threat Candida, including the emerging drug-resistant C. auris. The AR Lab Network also identifies germs that could be used to support researchers in developing new diagnostics and more treatment options through the CDC AR Isolate Bank. Learn more about the AR Lab Network and AR investments in your state.